Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 330 (RNA5SP330) is classified as a pseudogene related to the 5S ribosomal RNA gene family[1][2]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they are typically not transcribed or translated into functional products[1]. 5S ribosomal RNA itself is an important component of the large ribosomal subunit and essential for protein biosynthesis, but RNA5SP330 does not produce functional RNA, and there is no evidence that it has a biological or therapeutic role[1][2]. This locus is not considered a therapeutic target (e.g., not a receptor, enzyme, transporter), nor does it have known implications in disease, biomarkers, or pharmacological intervention[1][2]. If your interest is in 5S ribosomal RNA as a functional molecule, that is distinct from its pseudogenes. Pseudogenes have limited or no known biological role, and most databases list RNA5SP330 only as a nonfunctional genomic element[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 330 (RNA5SP330).